Medical Properties Trust (NYSE:MPW) has produced some seriously nice growth in recent quarters. Not only have revenues jumped around 200% since 2013, but net income also has jumped a whopping 227% in the same time frame. So why is the stock trading at less than 20x last year’s earnings? The answer is debt.
Medical Properties Trust invests in real estate suitable for medical uses. It’s a cool concept, because let’s face it, healthcare has a lot of money. Unfortunately the company has initiated a ton of financing in order to do it. The investment becomes a question of how much you’re willing to stomach in regards to long-term liabilities. On the one hand, it offers exposure to real estate in the most insulated market in the world, healthcare. It offers a great dividend, and historical trends of increasing revenue. On the other hand, its interest expenses could rise with rates, and the share counts are increasing quickly.
The growth story
The growth has been phenomenal. On an annual basis, revenues are on pace to hit $1 billion within the next few years. The aforementioned 227% increase in net income over a five-year period brought MPW’s fiscal 2017 net income to $288.38 million. 2018 looks to keep the positive momentum alive with a first-quarter worth discussion.
Best Medical Stocks To Watch For 2018: Sorrento Therapeutics, Inc.(SRNE)
Advisors’ Opinion:
- [By ]
Sorrento Therapeutics (SRNE) : “This is the kind of speculative stock that I like.”
Geron (GERN) : “Let’s stick with high quality like Thermo Fisher Scientific (TMO) .”
- [By ]
In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .
- [By William Romov]
San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.
On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”
Best Medical Stocks To Watch For 2018: (LGEAF)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
Coherent’s ELA deposition technology for LTPS backplane isn’t used in OLED TVs, where LG (OTC:LGEAF) uses metal oxide backpanes. There was some worry by analysts whether that technology could migrate to the smartphone panel market which CEO Ambroseo could not dispel entirely, but he argued that it has not been demonstrated suitable for handsets or battery-powered devices at this point.
Best Medical Stocks To Watch For 2018: Merit Medical Systems Inc.(MMSI)
Advisors’ Opinion:
- [By Lisa Levin]
Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent - [By Shane Hupp]
Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.
Best Medical Stocks To Watch For 2018: Myers Industries, Inc.(MYE)
Advisors’ Opinion:
- [By Stephan Byrd]
Myers Industries, Inc. (NYSE:MYE) Director Frederic Jack Liebau, Jr. bought 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 30th. The stock was purchased at an average cost of $19.28 per share, for a total transaction of $19,280.00. Following the completion of the transaction, the director now directly owns 28,957 shares in the company, valued at approximately $558,290.96. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
- [By Max Byerly]
Newell Brands (NYSE: NWL) and Myers Industries (NYSE:MYE) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.
Best Medical Stocks To Watch For 2018: Yum! Brands, Inc.(YUM)
Advisors’ Opinion:
- [By Stephan Byrd]
Burney Co. increased its holdings in shares of Yum! Brands (NYSE:YUM) by 475.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 44,278 shares of the restaurant operator’s stock after acquiring an additional 36,582 shares during the quarter. Burney Co.’s holdings in Yum! Brands were worth $3,769,000 at the end of the most recent quarter.
- [By Logan Wallace]
Public Employees Retirement Association of Colorado reduced its position in shares of Yum! Brands (NYSE:YUM) by 6.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 59,869 shares of the restaurant operator’s stock after selling 3,827 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Yum! Brands were worth $5,097,000 as of its most recent SEC filing.
- [By Max Byerly]
In other Yum! Brands news, CEO Brian R. Niccol sold 2,294 shares of Yum! Brands stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $84.90, for a total value of $194,760.60. Following the completion of the transaction, the chief executive officer now directly owns 10,160 shares of the company’s stock, valued at approximately $862,584. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Brian R. Niccol sold 945 shares of Yum! Brands stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $79.90, for a total value of $75,505.50. Following the completion of the transaction, the chief executive officer now directly owns 10,785 shares of the company’s stock, valued at $861,721.50. The disclosure for this sale can be found here. Insiders own 0.63% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Yum! Brands (YUM) Given News Sentiment Rating of 0.13” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3377799/yum-brands-yum-given-news-sentiment-rating-of-0-13.html.
About Yum! Brands
Best Medical Stocks To Watch For 2018: Carrizo Oil & Gas, Inc.(CRZO)
Advisors’ Opinion:
- [By Jon C. Ogg]
Carrizo Oil & Gas Inc. (NASDAQ: CRZO) was maintained as Buy but the price target was cut to $44 from $45 at Stifel.
CBS Corp. (NYSE: CBS) was reiterated as Buy with a $79 price target (versus a $52.42 close) at Argus. The firm was very positive about its individual prospects but was still very concerned about a possible re-merger with Viacom.
- [By Shane Hupp]
Carrizo Oil & Gas Inc (NASDAQ:CRZO) – Analysts at SunTrust Banks increased their Q3 2018 EPS estimates for shares of Carrizo Oil & Gas in a research note issued on Sunday, June 3rd. SunTrust Banks analyst N. Dingmann now expects that the oil and gas producer will earn $0.84 per share for the quarter, up from their prior estimate of $0.75. SunTrust Banks currently has a “Buy” rating and a $25.00 target price on the stock. SunTrust Banks also issued estimates for Carrizo Oil & Gas’ Q4 2018 earnings at $0.91 EPS, FY2018 earnings at $2.85 EPS, FY2019 earnings at $4.13 EPS and FY2020 earnings at $4.20 EPS.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Carrizo Oil & Gas (CRZO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
